secbutabarbital has been researched along with meprobamate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Busto, UE; Greenblatt, DJ; Kaplan, HL; Sellers, EM; Zawertailo, LA | 1 |
1 review(s) available for secbutabarbital and meprobamate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for secbutabarbital and meprobamate
| Article | Year |
|---|---|
Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital.
Topics: Adult; Analysis of Variance; Barbiturates; Behavior, Addictive; Dose-Response Relationship, Drug; Female; Humans; Male; Meprobamate; Psychomotor Performance; Substance-Related Disorders; Triazolam | 2003 |